Cheng, K.-C.; Li, Y.-X.; Shieh, P.-C.; Cheng, J.-T.; Hsu, C.-C.
Liraglutide Activates Glucagon-Like Peptide 1 Receptor to Attenuate Hyperglycemia through Endogenous Beta-Endorphin in Diabetic Rats. Pharmaceuticals 2020, 13, 407.
https://doi.org/10.3390/ph13110407
AMA Style
Cheng K-C, Li Y-X, Shieh P-C, Cheng J-T, Hsu C-C.
Liraglutide Activates Glucagon-Like Peptide 1 Receptor to Attenuate Hyperglycemia through Endogenous Beta-Endorphin in Diabetic Rats. Pharmaceuticals. 2020; 13(11):407.
https://doi.org/10.3390/ph13110407
Chicago/Turabian Style
Cheng, Kai-Chun, Ying-Xiao Li, Po-Chuen Shieh, Juei-Tang Cheng, and Chia-Chen Hsu.
2020. "Liraglutide Activates Glucagon-Like Peptide 1 Receptor to Attenuate Hyperglycemia through Endogenous Beta-Endorphin in Diabetic Rats" Pharmaceuticals 13, no. 11: 407.
https://doi.org/10.3390/ph13110407
APA Style
Cheng, K.-C., Li, Y.-X., Shieh, P.-C., Cheng, J.-T., & Hsu, C.-C.
(2020). Liraglutide Activates Glucagon-Like Peptide 1 Receptor to Attenuate Hyperglycemia through Endogenous Beta-Endorphin in Diabetic Rats. Pharmaceuticals, 13(11), 407.
https://doi.org/10.3390/ph13110407